Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraneuroma vs Perineuroma Botulinum Toxin Type A for Chronic Neuroma Pain
NCT07624877Completed
- Sponsor
- Ukrainian Society of Regional Anesthesia and Pain Therapy
- Start
- Oct 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in Neuroma (2 arms), sponsored by Ukrainian Society of Regional Anesthesia and Pain Therapy. Primary endpoint: Change in chronic neuroma pain intensity at 12 weeks. Started Oct 2026; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Neuroma
Beyond the preview
Go deeper on NCT07624877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07624877.